New registry aims to unravel mysteries of statin side effects
NCT ID NCT04975594
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This registry is following 1,000 people who have trouble tolerating statins, a common cholesterol-lowering drug. Researchers will track how often treatments are changed, cholesterol levels, and quality of life over time. The goal is to better understand this condition and improve heart disease prevention for those affected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help doctors better manage cholesterol in people who cannot take statins, potentially reducing heart disease risk.
- What could go wrong
- This is an observational registry, not a treatment trial, so it will not directly test any new drug or therapy. Results may not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Uniklinik Leipzig
Leipzig, Saxony, 04103, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A diet designed for puerto rico: can traditional foods fight heart disease and diabetes?
- Can a smartphone app help lower bad cholesterol?
- Heart drug showdown: which statin spares your blood sugar?
- Aerobic exercise may tame multiple chronic conditions in postmenopausal women
- Bee product may boost health in oral cancer survivors
- Could AI help pharmacists give better advice?